Current Opinion in Pharmacology

Papers
(The H4-Index of Current Opinion in Pharmacology is 27. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Recent advances in emerging PCOS therapies117
Corrigendum to “From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling” [COPHAR 76 (2024) 102458]110
Editorial Board98
The P2X7 purinoceptor in pathogenesis and treatment of dystrophino- and sarcoglycanopathies83
Therapeutic hurdles in acute myeloid leukemia: Leukemic stem cells, inflammation and immune dysfunction69
Advances in pain therapeutics: Targets, mechanisms, and translational frontiers52
From “contraindicated” to “first line” – Current mechanistic insights beyond canonical β-receptor signaling52
Native botulinum toxin type A vs. redesigned botulinum toxins in pain: What did we learn so far?49
Lipid raft disruption as an opportunity for peripheral analgesia47
The role of extracellular ATP in homeostatic immune cell migration42
Considerations for individualized first-line systemic treatment in advanced hepatocellular carcinoma40
Photo-isomerizable tweezers to probe ionotropic receptor mechanisms38
Optofluidic neural interfaces for in vivo photopharmacology38
Editorial Board37
Gastrointestinal issue: Advances in gastrointestinal oncology35
CRISPR-Cas9 in acute myeloid leukaemia: Current state-of-art and future perspectives34
Editorial overview: Special issue on “Rheumatology: Therapeutic advances for autoimmune and musculoskeletal diseases”34
Optic nerve regeneration: Potential treatment approaches34
Pancreatic alpha cells and glucagon secretion: Novel functions and targets in glucose homeostasis34
Editorial Board33
Advanced microneedle arrays for transdermal antibiotic delivery31
Dyslipidemia and diabetes mellitus: Role of lipoprotein species and interrelated pathways of lipid metabolism in diabetes mellitus30
Three-dimensional culture models to study glioblastoma — current trends and future perspectives29
Pharmaceutical therapies targeting autophagy for the treatment of age-related macular degeneration29
Emerging mutations in the SARS-CoV-2 variants and their role in antibody escape to small molecule-based therapeutic resistance28
Allogeneic double-negative T-cell therapy for acute myeloid leukemia28
Current state of CFTR modulators for treatment of Cystic Fibrosis27
Innovative pipeline therapeutics in IBD: anti-TL1A and bispecific antibodies27
Paeoniflorin is a promising natural monomer for neurodegenerative diseases via modulation of Ca2+ and ROS homeostasis27
0.20021510124207